|
TRIM35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.137800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.221400E-01 |
| Normal-vs-Stage2 |
6.469200E-01 |
| Normal-vs-Stage3 |
8.812400E-01 |
| Normal-vs-Stage4 |
9.906200E-01 |
| Stage1-vs-Stage2 |
8.049200E-01 |
| Stage1-vs-Stage3 |
2.255000E-01 |
| Stage1-vs-Stage4 |
4.432000E-01 |
| Stage2-vs-Stage3 |
5.484000E-01 |
| Stage2-vs-Stage4 |
6.663200E-01 |
| Stage3-vs-Stage4 |
8.754800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.590600E-01 |
| Normal-vs-AfricanAmerican |
2.445000E-01 |
| Normal-vs-Asian |
6.949800E-01 |
| Caucasian-vs-AfricanAmerican |
4.267600E-01 |
| Caucasian-vs-Asian |
9.193600E-01 |
| AfricanAmerican-vs-Asian |
4.244600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.212800E-01 |
| Normal-vs-Female |
4.456800E-01 |
| Male-vs-Female |
1.620850E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.651800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.515600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.438600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.824800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.350600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.599800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.692800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.329400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.322600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.424000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.807800E-01 |
| Classical-VS-Follicular |
1.82998999999073E-05 |
| Classical-VS-Other |
1.205000E-01 |
| Classical-VS-Normal |
1.047550E-01 |
| Tall-VS-Follicular |
6.418200E-02 |
| Tall-VS-Other |
2.750000E-01 |
| Tall-VS-Normal |
6.070600E-01 |
| Follicular-VS-Other |
9.284000E-01 |
| Follicular-VS-Normal |
1.050190E-01 |
| Other-VS-Normal |
3.752200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.882200E-01 |
| Normal-vs-N1 |
5.402000E-01 |
| N0-vs-N1 |
4.699600E-01 |
|
|
